☰

Zhenya Ni, Ph.D. - Publications

Affiliations: 
2008 Molecular Veterinary Biosciences University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Laskowski TJ, Van Caeneghem Y, Pourebrahim R, Ma C, Ni Z, Garate Z, Crane AM, Li XS, Liao W, Gonzalez-Garay M, Segovia JC, Paschon DE, Rebar EJ, Holmes MC, Kaufman D, et al. Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects. Stem Cell Reports. PMID 27396937 DOI: 10.1016/J.Stemcr.2016.06.003  0.49
2015 Frishman-Levy L, Shemesh A, Bar-Sinai A, Ma C, Ni Z, Frenkel S, Muench V, Bruckmueller H, Vokuhl C, Debatin KM, Eckert C, Stanulla M, Schrappe M, Campbell KS, Loewenthal R, et al. Central nervous system acute lymphoblastic leukemia: role of natural killer cells. Blood. 125: 3420-31. PMID 25896649 DOI: 10.1182/Blood-2014-08-595108  0.527
2015 Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B. Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells. Plos One. 10: e0121788. PMID 25816339 DOI: 10.1371/Journal.Pone.0121788  0.641
2015 Hermanson DL, Ni Z, Kaufman DS. Human pluripotent stem cells as a renewable source of natural killer cells Hematopoietic Differentiation of Human Pluripotent Stem Cells. 69-79. DOI: 10.1007/978-94-017-7312-6_5  0.431
2014 Ni Z, Knorr DA, Bendzick L, Allred J, Kaufman DS. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Stem Cells (Dayton, Ohio). 32: 1021-31. PMID 24307574 DOI: 10.1002/Stem.1611  0.447
2013 Ni Z, Knorr DA, Kaufman DS. Hematopoietic and nature killer cell development from human pluripotent stem cells. Methods in Molecular Biology (Clifton, N.J.). 1029: 33-41. PMID 23756940 DOI: 10.1007/978-1-62703-478-4_3  0.512
2013 Knorr DA, Ni Z, Hermanson D, Hexum MK, Bendzick L, Cooper LJ, Lee DA, Kaufman DS. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Translational Medicine. 2: 274-83. PMID 23515118 DOI: 10.5966/sctm.2012-0084  0.468
2013 Hermanson DL, Ni Z, Knorr DA, Bendzick L, Pribyl LJ, Geller M, Kaufman DS. Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells Blood. 122: 896-896. DOI: 10.1182/Blood.V122.21.896.896  0.602
2013 Frishman-Levy L, Shemesh A, Frenkel S, Bar-Sinai A, Ni Z, Kaufman DS, Meyer LH, Cario G, Hochman J, Progador A, Izraeli S. The Regulation Of Central Nervous System Acute Lymphoblastic Leukemia By Natural Killer Cells Blood. 122: 1393-1393. DOI: 10.1182/Blood.V122.21.1393.1393  0.46
2011 Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/Jvi.01774-10  0.379
2011 Knorr DA, Ni Z, Bock A, Ramakrishnan VG, Kumar S, Kaufman DS. Pluripotent Stem Cell-Derived Human Natural Killer Cells with Potent Anti-Multiple Myeloma Activity, Blood. 118: 4034-4034. DOI: 10.1182/Blood.V118.21.4034.4034  0.579
2010 Wang Y, Zhang AC, Ni Z, Herrera A, Walcheck B. ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 184: 4447-54. PMID 20220092 DOI: 10.4049/Jimmunol.0902925  0.548
2010 Knorr DA, Ni Z, Hexum MK, Gussiaas A, Hong MK, Walsh P, Kaufman DS. Differentiation of Human Natural Killer Cells From Pluripotent Stem Cells In a Feeder Free System Amenable to Clinical Translation Blood. 116: 107-107. DOI: 10.1182/Blood.V116.21.107.107  0.575
2009 Ni Z, Walcheck B. Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation Clinical Immunology. 133: 257-264. PMID 19665434 DOI: 10.1016/J.Clim.2009.07.010  0.672
2009 Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280  0.527
2008 Martin CH, Woll PS, Ni Z, Zúñiga-Pflücker JC, Kaufman DS. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood. 112: 2730-7. PMID 18621931 DOI: 10.1182/Blood-2008-01-133801  0.525
2007 Ni Z, Walcheck B. Varied levels of reactivity by different E-selectin/Fc constructs with cutaneous lymphocyte-associated antigen (CLA)+ CD4+ T cells Immunology Letters. 108: 179-182. PMID 17222460 DOI: 10.1016/J.Imlet.2006.12.002  0.647
2007 Ni Z. The MAb CHO-131 Identifies a Subset of Cutaneous Lymphocyte-Associated Antigen T cells Enriched in P-Selectin Binding Cells Journal of Allergy and Clinical Immunology. 119: S92. DOI: 10.1016/J.JACI.2006.11.388  0.515
2006 Ni Z, Campbell JJ, Niehans G, Walcheck B. The monoclonal antibody CHO-131 identifies a subset of cutaneous lymphocyte-associated antigen T cells enriched in P-selectin-binding cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 4742-8. PMID 16982914 DOI: 10.4049/Jimmunol.177.7.4742  0.65
Show low-probability matches.